<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21-medicina-56-00386">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Furuhashi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mita</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Moniwa</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Hoshina</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Ishimura</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Fuseya</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Yuki Watanabe</surname>
    <given-names>H.Y.</given-names>
   </name>
   <name>
    <surname>Yoshida</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Shimamoto</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Miura</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension</article-title>
  <source>Hypertens. Res.</source>
  <year>2015</year>
  <volume>38</volume>
  <fpage>252</fpage>
  <lpage>259</lpage>
  <pub-id pub-id-type="doi">10.1038/hr.2015.2</pub-id>
  <pub-id pub-id-type="pmid">25672659</pub-id>
 </element-citation>
</ref>
